Mindfulness Based Intervention on the COVID-19 Related Distress and Mobile Addiction

June 10, 2022 updated by: Zia-un-nisa, Fatima Jinnah Women University

Impact of Mindfulness Based Intervention on the COVID-19 Related Distress and Mobile Addiction During Pandemic: A Randomized Control Trails

The interventional study would be conducted to investigate the efficacy of mindfulness based intervention in order to treat psychological stress(anxiety, depression, and stress related COVID-19), and mobile phone addiction during COVID-19 pandemic.

Study Overview

Status

Not yet recruiting

Detailed Description

In the current study the data was collected from the young adults (age range 19-35 years). The high scorer from the sample selected from the participants in both control and experimental groups. furthermore, the mindfulness based stress reduction intervention was given to the experimental group. The mindfulness based stress reduction intervention comprised eight weeks period. After the provision of intervention the data for the second phase would be collected.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Punjab
      • Rawalpindi, Punjab, Pakistan, 46000
        • Zia-Un Nisa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 35 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The participants fulfil the age criteria, students from public and private universities, and provided signed informed consent.

Exclusion Criteria:

  • Participant suffering from chronic physical or psychological disorder. In addition participant who experience death of loved ones during COVID-19 pandemic.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Mindfulness based stress reduction
mindfulness based stress reduction intervention was used to treat psychological and addiction problems of the individuals
The aim of the psychological intervention to reduce the mental health problems of the participants.
OTHER: Relaxation Exercise
the control group was provided with the relaxation technique.
The aim of the psychological intervention to reduce the mental health problems of the participants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
COVID-19 related Stress
Time Frame: 35 minutes
COVID-19 related stress scale(<5 minimum, >72 Maximum)
35 minutes
anxiety and depression
Time Frame: 15 minutes
hospitalized anxiety and depression scale (<7 minimum, >21 Maximum)
15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mobile phone addiction
Time Frame: 35 minutes
smartphone addiction scale (33 minimum, 198maximum)
35 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: zia-un Nisa, Assisstant professor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

August 1, 2022

Primary Completion (ANTICIPATED)

October 1, 2022

Study Completion (ANTICIPATED)

December 1, 2022

Study Registration Dates

First Submitted

February 24, 2022

First Submitted That Met QC Criteria

June 10, 2022

First Posted (ACTUAL)

June 13, 2022

Study Record Updates

Last Update Posted (ACTUAL)

June 14, 2022

Last Update Submitted That Met QC Criteria

June 10, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The investigator has not plan to share data without taking permission from the study participants.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychological Stress

Clinical Trials on Mindfulness Based stress reduction

3
Subscribe